Placebo: GDC-8264 clinical trials

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events

This study is looking into a new medication called GDC-8264. It aims to see if GDC-8264 can help prevent kidney problems sometimes caused by heart surgery in people who might be at higher risk. It's a key step in developing new ways to protect your kidneys.